ECTRIMS-ACTRIMS 2023 survey

September 20, 2023

Recommend to a Colleague print

 

Help make the NeuroSens coverage of MSMilan 2023 (The 9th Joint ECTRIMS-ACTRIMS Meeting) relevant to you.

Complete the survey below to tell us what topics are of greatest interest to you.

This poll is currently disabled.

Recommend to a Colleague

Related Posts

• Biomarkers after stopping treatment may identify at-risk MS patients
  November 30, 2023
• Exploring the lung-brain axis in MS
  November 29, 2023
• Neurofilament-light chain (NfL) as a biomarker of response to higher-efficacy disease-modifying therapies
  November 22, 2023
• OCT – diagnosis and prognosis
  November 8, 2023
• Novel treatments: targeting CD40 ligand
  November 1, 2023

Go back to home page